Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations: LLC ARENSIA Exploratory Medicine Tbilisi, Georgia

IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova

Hospital Beata Maria Ana Madrid, Spain

Hospital Fundación Jiménez Diaz Madrid, Spain

View all 17 locations

View Trial Details

Recruiting

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma

NCT07562022

Conditions: Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

NCT07463807

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases

NCT07727083

Conditions: Aggressive NK-cell Leukemia, DNA Virus Infections, Epstein-Barr Virus Infections, +24 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.

NCT06762431

Conditions: Chronic Disease, Chronic Lymphocytic Leukaemia (CLL), Disease Attributes, +15 more
Locations: Hematology/Oncology department Vitebsk, Select A State, Belarus

View Trial Details

Recruiting

A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

NCT03911128

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Aalborg University Hospital, Dept of Paediatrics Aalborg, Denmark

Aarhus University Hospital Aarhus, Denmark

Aarhus University Hospital, Child and Adolescent Health Aarhus, Denmark

Rigshospitalet, Dept of Haematology Copenhagen, Denmark

View all 57 locations

View Trial Details

Recruiting

eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation

NCT07469592

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Recruiting

Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients

NCT07763054

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Agranulocytosis, +43 more
Locations: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine Hainan, China

View Trial Details

Recruiting

Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)

NCT07053059

Conditions: Acute Lymphocytic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

NCT07280013

Conditions: Bites and Stings, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

UC Davis Comprehensive Cancer Center Sacramento, California, United States

UCLA Health, Jonsson Comprehensive Cancer Center Santa Monica, California, United States

University of Florida Gainesville, Florida, United States

View all 20 locations

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions